InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Discover the complete record of transactions filed by Ryan Barbara, Director. Officer active across 3 companies, notably Indivior Pharmaceuticals, Inc.. Aggregated, 5 disclosures have been published. Total volume traded: €9k. The latest transaction was disclosed on 13 May 2026 — Attribution. Regulator: SEC (Form 4). All data is openly available.
Declarations5 total
06,518 shares0
Common Stock
SEC:0001827169-26-000013·
06,518 shares0
Common Stock
SEC:0001827169-26-000013:0·
€9,38610,526 shares@ €0.8917100.0% of flow
Common Stock
SEC:0001493152-22-015911:0·
Ideal exit: 26 Feb 2023 (T+270)
08,588 shares0
Common Stock
SEC:0001493152-22-001529·
08,588 shares0
Common Stock
SEC:0001493152-22-001529:0·
5 of 5 declarations
About Ryan Barbara
Barbara Ryan serves as a Board Member of Indivior Pharmaceuticals, Inc. and INVO Bioscience, Inc. She participates in the governance of these companies by overseeing operations and contributing to strategic decision-making. Her role is essential in ensuring compliance and transparency in their activities.
